PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Hold” by Analysts
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has […]
27 Sep 15:30 · The Cerbat Gem